Since Bcl-xL overexpression is closely related to cancer cell survival and acquisition of a cancer cell’s invasiveness potential, it is likely that DOX-elicited TEV from cells overexpressing Bcl-xL could also convey anti-apoptotic and prometastatic signals to the recipient cells [28,61]. Here, BCL2L1 is linked to cancer.